Annals of Pediatric Cardiology
About us | Current Issue | Archives | Ahead of Print | Instructions | Submission | Subscribe | Advertise | Contact | Login 
  Instructions 
  Search 
  My preferences 

 


This article has been cited by
1The Major Molecular Causes of Familial Hypercholesterolemia
Truong Phuong Kim,Lao Thuan Duc,Huyen Le Thuy Ai
Asian Journal of Pharmaceutical Research and Health Care.2018;10(2)60
[DOI]
2The Major Molecular Causes of Familial Hypercholesterolemia
Tondy Tondy,I Nyoman Ehrich Lister,Ali Napiah Nasution,Sukirman Lie
Asian Journal of Pharmaceutical Research and Health Care.2021;10(2)1
[DOI]
3Development of Aortic Valve Disease in Familial Hypercholesterolemic Swine: Implications for Elucidating Disease Etiology
Ana M. Porras,Dhanansayan Shanmuganayagam,Jennifer J. Meudt,Christian G. Krueger,Timothy A. Hacker,Peter S. Rahko,Jess D. Reed,Kristyn S. Masters
Journal of the American Heart Association.2015;4(10)1
[DOI]
4Fat and Protein Combat Triggers Immunological Weapons of Innate and Adaptive Immune Systems to Launch Neuroinflammation in Parkinson’s Disease
Shelby Loraine Hatton,Manoj Kumar Pandey
International Journal of Molecular Sciences.2022;23(3)1089
[DOI]
5Screening for Familial Hypercholesterolaemia: Universal or Cascade? A Critique of Current FH Recognition Strategies
D. R. Sullivan,L. Freeman,L. Molloy,G. Williams
Current Cardiovascular Risk Reports.2015;9(2)1089
[DOI]
6Screening for Familial Hypercholesterolaemia: Universal or Cascade? A Critique of Current FH Recognition Strategies
Vesna Vucic,Romana Masnikosa
Current Cardiovascular Risk Reports.2017;9(2)1089
[DOI]
7Screening for Familial Hypercholesterolaemia: Universal or Cascade? A Critique of Current FH Recognition Strategies
Alberto Quaglia,Eve A. Roberts,Michael Torbenson
Current Cardiovascular Risk Reports.2018;9(2)111
[DOI]
8Screening for Familial Hypercholesterolaemia: Universal or Cascade? A Critique of Current FH Recognition Strategies
V. Vucic,Z. Cvetkovic
Current Cardiovascular Risk Reports.2016;9(2)47
[DOI]
9A Splice Region Variant in LDLR Lowers Non-high Density Lipoprotein Cholesterol and Protects against Coronary Artery Disease
Solveig Gretarsdottir,Hannes Helgason,Anna Helgadottir,Asgeir Sigurdsson,Gudmar Thorleifsson,Audur Magnusdottir,Asmundur Oddsson,Valgerdur Steinthorsdottir,Thorunn Rafnar,Jacqueline de Graaf,Maryam S. Daneshpour,Mehdi Hedayati,Fereidoun Azizi,Niels Grarup,Torben Jørgensen,Henrik Vestergaard,Torben Hansen,Gudmundur Eyjolfsson,Olof Sigurdardottir,Isleifur Olafsson,Lambertus A. Kiemeney,Oluf Pedersen,Patrick Sulem,Gudmundur Thorgeirsson,Daniel F. Gudbjartsson,Hilma Holm,Unnur Thorsteinsdottir,Kari Stefansson,Ruth J F Loos
PLOS Genetics.2015;11(9)e1005379
[DOI]
10A Brief Review of Cardiovascular Diseases, Associated Risk Factors and Current Treatment Regimes
Gagan D. Flora,Manasa K. Nayak
Current Pharmaceutical Design.2019;25(38)4063
[DOI]
11Post-transcriptional Regulation of PCSK9 by miR-191, miR-222, and miR-224
Parisa Naeli,Fatemeh Mirzadeh Azad,Mahshid Malakootian,Nabil G. Seidah,Seyed J. Mowla
Frontiers in Genetics.2017;8(38)4063
[DOI]
12Advancement in nanotechnology-based approaches for the treatment and diagnosis of hypercholesterolemia
Nidhi Gupta,Nikita Sharma,Sandeep K. Mathur,Ramesh Chandra,Surendra Nimesh
Artificial Cells, Nanomedicine, and Biotechnology.2018;46(sup1)188
[DOI]
13Genetic, hematological, and immunological disorders transmissible with liver transplantation
Amy Tan,Sander S. Florman,Thomas D. Schiano
Liver Transplantation.2017;23(5)663
[DOI]
14Development of a Synthetic 3-ketosteroid ?1-dehydrogenase for the Generation of a Novel Catabolic Pathway Enabling Cholesterol Degradation in Human Cells
Brandon M. D’Arcy,Mark R. Swingle,Lindsay Schambeau,Lewis Pannell,Aishwarya Prakash,Richard E. Honkanen
Scientific Reports.2019;9(1)663
[DOI]
15Managing Clinical Heterogeneity: An Argument for Benefit-Based Action Limits
Sudarshan Ramachandran,Carola S. König,Geoffrey Hackett,Mark Livingston,Richard C. Strange
Journal of Engineering and Science in Medical Diagnostics and Therapy.2018;1(3)663
[DOI]
16FAMILIAL HYPERCHOLESTEROLAEMIA- REPORT OF A FAMILY
Venkatesh R. Giri,Pranit Farande,Petkar S N,Ajit Barve,Rikita Patel
Journal of Evolution of Medical and Dental Sciences.2018;7(12)1550
[DOI]
17FAMILIAL HOMOZYGOUS HYPERCHOLESTEROLAEMIA- A CASE REPORT
Shailaja Potdar,Jayesh Panot,Vandana Kumavat,Sunil Junagade
Journal of Evolution of Medical and Dental Sciences.2017;6(18)1461
[DOI]
18Advances in Pathophysiology of Calcific Aortic Valve Disease Propose Novel Molecular Therapeutic Targets
Alexia Hulin,Alexandre Hego,Patrizio Lancellotti,Cécile Oury
Frontiers in Cardiovascular Medicine.2018;5(18)1461
[DOI]
19Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors
Ivan Pecin,Merel L Hartgers,G Kees Hovingh,Ricardo Dent,Željko Reiner
European Journal of Preventive Cardiology.2017;24(13)1383
[DOI]
20The Malaysian HEalth and WellBeing AssessmenT (MyHEBAT) Study Protocol: An Initiation of a National Registry for Extended Cardiovascular Risk Evaluation in the Community
Al’aina Yuhainis Firus Khan,Anis Safura Ramli,Suraya Abdul Razak,Noor Alicezah Mohd Kasim,Yung-An Chua,Ahmad Zia Ul-Saufie,Mohd Amin Jalaludin,Hapizah Nawawi
International Journal of Environmental Research and Public Health.2022;19(18)11789
[DOI]
21Optimizing Diet, Weight, and Exercise in Adults With Familial Hypercholesterolemia
Linda Coughlin DeBeasi
The Journal for Nurse Practitioners.2017;13(9)603
[DOI]
22Expert and Advocacy Group Consensus Findings on the Horizon of Public Health Genetic Testing
Stephen Modell,Karen Greendale,Toby Citrin,Sharon Kardia
Healthcare.2016;4(1)14
[DOI]
23Intertriginous Xanthomas—Pathognomonic Cutaneous Markers of Homozygous Familial Hypercholesterolemia
Abheek Sil,Dibyendu Bikash Bhanja,Surajit Kumar Biswas
JAMA Dermatology.2021;157(10)1228
[DOI]
24The Challenge of Cardiovascular Diseases and Diabetes to Public Health: A Study Based on Qualitative Systemic Approach
Marilia Sá Carvalho,Claudia Medina Coeli,Dóra Chor,Rejane Sobrino Pinheiro,Maria de Jesus Mendes da Fonseca,Luiz Carlos de Sá Carvalho,Rodrigo Huerta-Quintanilla
PLOS ONE.2015;10(7)e0132216
[DOI]
25Novel Lipidomic Biomarkers in Hyperlipidemia and Cardiovascular Diseases: An Integrative Biology Analysis
Sneha Rai,Sonika Bhatnagar
OMICS: A Journal of Integrative Biology.2017;21(3)132
[DOI]
26Immuno-regenerative biomaterials for in situ cardiovascular tissue engineering – Do patient characteristics warrant precision engineering?
B.J. de Kort,S.E. Koch,T.B. Wissing,M.M. Krebber,C.V.C. Bouten,A.I.P.M. Smits
Advanced Drug Delivery Reviews.2021;178(3)113960
[DOI]
27The Natural Products as Hydroxymethylglutaryl-Coa Reductase Inhibitors
Hayrettin Ozan Gulcan,Serkan Yigitkan,Ilkay Erdogan Orhan
Letters in Drug Design & Discovery.2019;16(10)1130
[DOI]
28Aplicación de la secuenciación masiva de nueva generación al diagnóstico molecular de la hipercolesterolemia familiar
Estefanía Martínez-Barrios,Ana Isabel Martínez-Puchol,Alba Roset,Daniel Zambón,Joan Clària,Montserrat Bernat
Revista del Laboratorio Clínico.2015;8(1)8
[DOI]
29Human Placental Intracellular Cholesterol Transport: A Focus on Lysosomal and Mitochondrial Dysfunction and Oxidative Stress
Maria Jose Yañez,Andrea Leiva
Antioxidants.2022;11(3)500
[DOI]
30Liver transplantation for pediatric inherited metabolic disorders: Considerations for indications, complications, and perioperative management
Kimihiko Oishi,Ronen Arnon,Melissa P. Wasserstein,George A. Diaz
Pediatric Transplantation.2016;20(6)756
[DOI]
31Liver transplantation for pediatric inherited metabolic disorders: Considerations for indications, complications, and perioperative management
Eric M. Tretter,Patrick J. Oliver,Sainath R. Kotha,Travis O. Gurney,Drew M. Nassal,Jodi C. McDaniel,Thomas J. Hund,Narasimham L. Parinandi
Pediatric Transplantation.2022;20(6)379
[DOI]
32Impact of cholesterol on disease progression
Chun-Jung Lin,Cheng-Kuo Lai,Min-Chuan Kao,Lii-Tzu Wu,U-Ging Lo,Li-Chiung Lin,Yu-An Chen,Ho Lin,Jer-Tsong Hsieh,Chih-Ho Lai,Chia-Der Lin
BioMedicine.2015;5(2)379
[DOI]
33Familial Hypercholesterolemia
Victoria Enchia Bouhairie,Anne Carol Goldberg
Cardiology Clinics.2015;33(2)169
[DOI]
34Classification of Familial Hypercholesterolaemia Using Ordinal Logistic Regression
Muhammad Hamizan Jamaludin,Yap Bee Wah,Hapizah Mohd Nawawi,Chua Yung-An,Marshima Mohd Rosli,Muthukkaruppan Annamalai
Pertanika Journal of Science and Technology.2020;28(4)169
[DOI]
35Young Age Onset Multivascular Pathology in a Patient with Severe Dyslipidemia: an Incidental Case or a Particular Type of Familial Hypercholesterolemia?
Radu-Stefan Miftode,Ana-Maria Haba,Andreea-Maria Ursaru,Antoniu Octavian Petris,Ovidiu Mitu
Romanian Journal of Cardiology.2022;0(0)169
[DOI]
36The Compositional and Functional Properties of Kombucha: A Literature Review
Jae Young Kim,Hye Jung Shin,Hyungjin Lukas Kim,Hoon Park,Phil Kun Kim,Steven Park,Sae Hun Kim
Food Engineering Progress.2020;24(1)1
[DOI]
37Pediatric Lipid Disorders
Scott Leopold,Justin P. Zachariah
Pediatric Annals.2021;50(3)1
[DOI]
38Familial Hypercholesterolemia
Victoria Enchia Bouhairie,Anne Carol Goldberg
Endocrinology and Metabolism Clinics of North America.2016;45(1)1
[DOI]
39Familial Hypercholesterolemia
Nalini M. Rajamannan
Endocrinology and Metabolism Clinics of North America.2018;45(1)73
[DOI]
40The Extending Spectrum of NPC1-Related Human Disorders: From Niemann–Pick C1 Disease to Obesity
Amel Lamri,Marie Pigeyre,William S Garver,David Meyre
Endocrine Reviews.2018;39(2)192
[DOI]
41RSSDI consensus recommendations for dyslipidemia management in diabetes mellitus
Banshi Saboo,Sanjay Agarwal,Brij Mohan Makkar,Rajeev Chawla,Sujoy Ghosh,Vijay Viswanathan,Sunil Gupta,Ch. Vasanth Kumar,Anuj Maheshwari,L. Sreenivasamurthy,Rakesh Kumar Sahay,Sanjay Reddy,Shalini Jaggi,Jugal Kishor Sharma,Vijay Panikar,Anand Moses,Bikash Bhattacharjee,Pratap Jethwani,Sudhir Bhandari,J. P. S. Sawhney,Shashank Joshi,Saumitra Ray,S. V. Madhu,Bipin Sethi
International Journal of Diabetes in Developing Countries.2022;42(1)3
[DOI]